As the United States continues to focus on social distancing to combat COVID-19, more companies are revealing how the move home for their workers is impacting their business. Despite this, companies like Emerson’s ASCO and Aventics divisions continue to step up production on key technologies used in life sciences and laboratories, including ventilators, respirators, hospital beds and testing equipment, among others.
I spoke with Erik VanLaningham, vice president of global marketing for industrial automation at Emerson and Andy Duffy, vice president of sales America for fluid and pneumatic control at Emerson, about how the company’s fluid control and automation technologies are under extra production at this time, despite remote working and more challenges.